Panelists discuss how recent advancements in nonsteroidal topical therapies—particularly roflumilast and tapinarof—are transforming psoriasis management by offering safe, effective, and well-tolerated alternatives that improve adherence, address challenges across skin types and body areas (especially the scalp), reduce reliance on steroids and systemics, and support individualized, equitable, and long-term care.
EP. 1: Challenges With Topical Psoriasis Treatments and the Need for Simpler Options
June 30th 2025Panelists discuss how topical therapies remain essential in psoriasis management across all severities, highlighting the need for simplified, steroid-sparing treatment options that are safe, effective, and easy to use—especially to improve adherence and address patient concerns about adverse effects and complexity.
EP. 2: Why Treating Scalp Psoriasis With Topicals Remains a Challenge
July 7th 2025Panelists discuss how treating scalp psoriasis remains challenging due to poor compatibility of traditional topicals with hair and scalp characteristics, emphasizing the need for cosmetically acceptable, well-tolerated formulations that improve adherence and reduce premature escalation to systemic therapy.
EP. 3: The Utility of Topical Treatment in Skin of Color
July 17th 2025Panelists discuss how diagnosing and treating psoriasis in patients with skin of color requires awareness of atypical presentations, hair and cultural considerations, and systemic treatment disparities, highlighting the value of safe, broadly effective, and cosmetically acceptable topicals to support earlier and more equitable care.
EP. 4: Designing the Ideal Topical: Relieving Itch and Improving Quality of Life
July 24th 2025Panelists discuss how an ideal topical for widespread psoriasis—including scalp and sensitive areas—would be a single, nonsteroidal, well-tolerated agent with steroidlike efficacy, capable of supporting both proactive flare prevention and rapid itch relief while improving adherence, quality of life, and long-term disease control.